MyFinsight
Home
Blog
About
Contact
Net loss
attributable to common...
-$56,159K
(-160.10%↓ Y/Y)
Net loss and
comprehensive loss
-$53,156K
(-182.10%↓ Y/Y)
Cumulative dividend on
redeemable convertible...
$2,844K
(8.26%↑ Y/Y)
Accretion of redeemable
convertible preferred stock...
$159K
(31.40%↑ Y/Y)
Income tax benefit
-$15,317K
(-120.71%↓ Y/Y)
Interest income, net
-$380K
(60.46%↑ Y/Y)
Other income, net
$38K
(1800.00%↑ Y/Y)
Advanced Wound Care
$29,482K
Surgical And Sports
Medicine
$6,768K
Net loss before
income taxes
-$68,473K
(-165.57%↓ Y/Y)
Total other income,
net
$418K
(-56.59%↓ Y/Y)
Product
$36,250K
Grant
$978K
Loss from operations
-$68,891K
(-157.57%↓ Y/Y)
Total revenue
$37,228K
(-57.06%↓ Y/Y)
Total operating
expenses
$106,119K
(18.28%↑ Y/Y)
Selling, general and
administrative
$65,186K
(-10.10%↓ Y/Y)
Cost of goods sold
$25,772K
(8.64%↑ Y/Y)
Research and development
$15,161K
(42.49%↑ Y/Y)
Back
Back
Income Statement
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)
source: myfinsight.com